or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    MRNA A 3.28 7.50
    DGX A 5.08 6.59
    ALNY F 0.19 6.36
    BNTX F 0.55 6.31
    LH D 2.41 6.07
    BIO F 1.84 3.93
    DVAX D -0.68 3.79
    PCVX D -1.17 3.71
    IMCR D 2.67 3.35
    ZLAB F 0.87 3.05
    VIR F 0.37 2.97
    OPK B 1.63 2.55
    BCRX F -0.68 2.35
    ARCT F 3.22 2.01
    HLVX F -1.31 1.63
    SIGA A 4.91 1.60
    FLGT F 0.39 1.59
    CVAC F 2.77 1.51
    NVAX F 2.95 1.45
    ABUS B 4.17 1.24
    ADPT F 2.79 1.09
    ALT D 1.34 1.06
    OSUR D 3.36 0.99
    RENB F -6.05 0.98
    OCGN B 0.81 0.97
    AZN A 1.03 0.95
    LLY D 1.96 0.87
    MRK A -0.05 0.87
    PFE F 0.23 0.87
    SNY C 1.15 0.86
    GILD F 0.12 0.85
    GSK C 1.60 0.85
    ABBV C 0.98 0.83
    ABT D 0.49 0.83
    ENTA C -2.16 0.83
    REGN C 0.80 0.83
    JNJ F 0.30 0.81
    TAK F 0.15 0.81
    CRMD B 3.22 0.67
    XBIT B 2.89 0.64
    VXRT F -2.24 0.39
    EBS F 6.02 0.26
    IFRX F -0.73 0.21
    CMRX F 1.25 0.21
    CVM F -2.65 0.21
    GRTS F -0.93 0.19
    CUE F -4.46 0.18
    VAXX F -25.82 0.14

    Represented by ETF Holdings

    Keywords: Medicine Biopharmaceutical Infectious Diseases Biotechnology Cancer S&P 500 Vaccines Influenza Life Sciences Coronavirus Immunology Pharmaceutical Products Disease Pharmaceutical Hypertension Infection Inflammation Medication Vaccination Antibiotics
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Devices Medical Instruments & Supplies

    Recent News for ETFMG Treatments Testing and Advancements ETF & its Holdings

    Date Stock Title
    Apr 23 ABT It’s Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team
    Apr 23 LLY TikTok to restrict weight loss drug promotion (updated)
    Apr 23 ABBV Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s among 10 stocks set to surge
    Apr 23 DGX Quest Diagnostics rises 5% on 2024 outlook raise, quarterly results
    Apr 23 ABUS Moderna Investors Should Beware Patent-Dispute Fallout
    Apr 23 MRNA Moderna Investors Should Beware Patent-Dispute Fallout
    Apr 23 TAK Neurocrine succeeds in mid-stage trial for Takeda-partnered depression drug
    Apr 23 CVAC CureVac BV FQ4 2023 Earnings Preview
    Apr 23 SNY Sanofi reportedly lining up banks for consumer products spinoff
    Apr 23 MRNA S&P 500 stocks with biggest estimated EPS declines for Q1
    Apr 23 DGX Quest Diagnostics Incorporated (DGX) Q1 2024 Earnings Call Transcript
    Apr 23 SNY Sanofi Asks Banks to Pitch for $20 Billion OTC Spinoff
    Apr 23 VAXX Why Vaxxinity (VAXX) Shares Are Volatile Today
    Apr 23 SNY Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
    Apr 23 CVAC CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%
    Apr 23 GILD Incyte (INCY) Earnings Expected to Grow: Should You Buy?
    Apr 23 ABBV Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
    Apr 23 LLY Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
    Apr 23 TAK Takeda Pharmaceutical: A Long-Term Cash Cow
    Apr 23 AZN AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
    GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.
    Biotechnology Life Sciences Biology Infectious Diseases Vaccines Vaccination Virology
    Back to the Main GERM Page...